Cyclic sulfonium salt, process for production of same, and α-glucosidase inhibitor comprising same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9073897
APP PUB NO 20140031394A1
SERIAL NO

13982715

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a novel cyclic sulfonium salt compound which is useful for the prevention or treatment of diabetes and the like. The present invention relates to a novel cyclic sulfonium salt compound represented by general formula (I) or (II), an isomer or solvate of the compound, or a pharmaceutically acceptable salt of the compound or the isomer or solvate. The present invention also relates to an α-glucosidase inhibitor, a pharmaceutical composition for preventing or treating diabetes, and an anti-diabetes food, each of which comprises the compound represented by general formula (I) or (II) and the like.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KINKI UNIVERSITYHIGASHI-OSAKA-SHI OSAKA 577-8502
DIABETYM CO LTD1-13-11 HIGASHISHINSAIBASHI CHUO-KU OSAKA-SHI OSAKA 542-0083

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Muraoka, Osamu Higashiosaka, JP 4 6
Tanabe, Genzoh Higashiosaka, JP 5 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 7, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00